Health Forum - Healthy Ageing at what cost?

Dr Brendan Shaw, Bernard Salt, Prof Deborah Schofield, Dr Andrew Pesce

December 8, 2010

"Healthy Ageing - At what cost

The annual excellence in health journalism awards will be presented prior to the forum.

On November 17 2010, Chairman of Medicines Australia Mr Will Delaat argued the significance of the Pharmaceutical Benefits Scheme Memorandum of Understanding with the Commonwealth – both for taxpayers and consumers.  Mr Delaat made the case for Parliament to pass the PBS legislation currently before the Senate and announced Medicines Australia’s four-point plan to ensure the medicines industry can continue to deliver better health outcomes and greater economic benefits to Australians.Mr Delaat referred to  Australia's ageing population and its implications during his address.

Australia's ageing population has major repercussions on the health industry and all Australians.  Join us to hear from a panel of experts as they share their views on what Australia's ageing population means and at what cost.

thumbnailDr Brendan Shaw - Chief Executive Medicines Australia

thumbnailBernard Salt - Trend Forecaster and Partner of KPMG

thumbnailProfessor Deborah Schofield - Professor and Chair of Health Economics University of Sydney

Dr Andrew Pesce - President of the Australian Medical Association.